Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 35 for “"Biologic agents"”.

  1. Veterinary Therapeutic and Biologic Agents in Virginia Sheep Production

    Biological and therapeutic agents are used in food animal production to maintain animal health and well being, prevent and treat disease, and to maintain or enhance production. Concerns about the use of pharmaceutical agents in food animal production have been raised, especially in relation to food …

    vt Repository record for Veterinary Therapeutic and Biologic Agents in Virginia Sheep Production (opens in a new tab)

  2. The effect of biologic agents on metabolic associated fatty liver disease in patients with inflammatory bowel disease

    … with IBD. Εmerging therapeutic choices of biologicals have modified the clinical course of IBD; however, their impact on IBD-associated MASLD has not been extensively evaluated. The prevalence of MASLD varies within patients with IBD, but it appears higher than in the general population in …

    greece Repository record for The effect of biologic agents on metabolic associated fatty liver disease in patients with inflammatory bowel disease (opens in a new tab)

  3. THE ROLE OF BIOLOGICS AND PERIODONTAL OSSEOUS TREATMENT FOR INFRABONY DEFECTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

    … is a standard surgical approach, adjunctive biologic agents have emerged as promising tools to enhance regeneration. This systematic review and meta-analysis evaluated the clinical efficacy of three biologics—Enamel Matrix Derivative (EMD), Platelet-Rich Fibrin (PRF), and recombinant human …

    penn Repository record for THE ROLE OF BIOLOGICS AND PERIODONTAL OSSEOUS TREATMENT FOR INFRABONY DEFECTS: A SYSTEMATIC REVIEW AND META-ANALYSIS (opens in a new tab)

  4. THE ANALYSIS OF EMDOGAIN BINDING AFFINITY FOR DIFFERENT PARTICULATE BONE GRAFT MATERIALS.

    … (Institut Straumann AG, Basel, Switzerland). The biologically inactive nature of many commercially available bone graft materials provides an opportunity for the addition of certain biologic materials to enhance the healing response. The development of an adequate carrier for biologic agents is a …

    temple Repository record for THE ANALYSIS OF EMDOGAIN BINDING AFFINITY FOR DIFFERENT PARTICULATE BONE GRAFT MATERIALS. (opens in a new tab)

  5. Assessment of Intra- and Inter-individual Variability of Outcome Measures in Ankylosing Spondylitis and the Efficacy and Adverse Effects of Anti-TNF Therapy

    … that has a highly variable disease course. Three biologic agents, adalimumab, etanercept, and infliximab, have been developed for the treatment of AS. We conducted three studies: 1) an exploratory analysis of a year-long longitudinal dataset to gain insight into the variability of disease …

    ottawa-retro Repository record for Assessment of Intra- and Inter-individual Variability of Outcome Measures in Ankylosing Spondylitis and the Efficacy and Adverse Effects of Anti-TNF Therapy (opens in a new tab)

  6. Associated risk factors and rate of relapse of plaque psoriasis following withdrawal of biologics

    … The most efficient treatments available are the biologic agents, that once initiated are often continued until further notice as discontinuation will likely lead to relapse. Many patients face withdrawal from these agents, reasons being multifactorial, and the risk of relapse often continues to …

    bu Repository record for Associated risk factors and rate of relapse of plaque psoriasis following withdrawal of biologics (opens in a new tab)

  7. Μακροχρόνια χορήγηση βιολογικών παραγόντων και αναπνευστική λειτουργία στην αγκυλοποιητική σπονδυλοαρθρίτιδα

    … motion improves after institution of biologic agents. Secondary objectives was the evaluation of the pattern of chest wall configuration during speech production, PFTs evaluation in these patients and to test if SNIP can be used alternatively to inspiratory muscle evaluation in these …

    greece Repository record for Μακροχρόνια χορήγηση βιολογικών παραγόντων και αναπνευστική λειτουργία στην αγκυλοποιητική σπονδυλοαρθρίτιδα (opens in a new tab)

  8. Geographic Differences in the Risk of Surgery in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

    … spending related to IBD management has been on biologic agents.These biologic agents are very costly and are thought to decrease the risk of surgery. The risks of surgery among patients with IBD in the Western world is well described. However, the risks of IBD surgery in Asian countries has not …

    calgary Repository record for Geographic Differences in the Risk of Surgery in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis (opens in a new tab)

  9. Κύηση και ιδιοπαθείς φλεγμονώδεις νόσοι του εντέρου: πανελλαδική καταγραφή

    … throughout gestation and more than 60% received biologic agents during pregnancy. Disease flares during pregnancy were recorded in 22.2% and 16.7% of pregnancies in the retrospective and prospective cohorts, respectively, with a higher frequency observed among patients with ulcerative colitis. In …

    greece Repository record for Κύηση και ιδιοπαθείς φλεγμονώδεις νόσοι του εντέρου: πανελλαδική καταγραφή (opens in a new tab)

  10. Κλινική και ανοσολογική μελέτη της επίδρασης των βιολογικών παραγόντων στη νεανική ιδιοπαθή αρθρίτιδα

    … to evaluate the long-term safety and efficacy of biologic agents in patients with Juvenile Idiopathic Arthritis (JIA) and b) to investigate the impact of anti TNFs on Τ cell activation and proliferation response. The safety and efficacy of infliximab etanercept adalimumab and anakinra were …

    greece Repository record for Κλινική και ανοσολογική μελέτη της επίδρασης των βιολογικών παραγόντων στη νεανική ιδιοπαθή αρθρίτιδα (opens in a new tab)

  11. Investigation of the possibilities for host modulation therapy for periodontal treatment

    … insights into the complexities of studying biologic agents in dental populations. Conclusion: HMT represents a promising adjunctive strategy in periodontal therapy, particularly for high-risk individuals. While current evidence supports the biological plausibility of targeting host pathways, …

    glasgow Repository record for Investigation of the possibilities for host modulation therapy for periodontal treatment (opens in a new tab) Download PDF for Investigation of the possibilities for host modulation therapy for periodontal treatment (opens in a new tab)

  12. Εκτίμηση του κόστους και της αποτελεσματικότητας από τη θεραπεία της ρευματοειδούς αρθρίτιδας με βιολογικούς παράγοντες

    … To compare the relative effectiveness of biological therapies approved for rheumatoid arthritis (RA) on health-related quality of life in patients diagnosed with RA. Also, a cost-effectiveness analysis was used to investigate of there is a therapy that optimizes the overall social benefit. …

    greece Repository record for Εκτίμηση του κόστους και της αποτελεσματικότητας από τη θεραπεία της ρευματοειδούς αρθρίτιδας με βιολογικούς παράγοντες (opens in a new tab)

  13. Evaluating ultrasound confirmed enthesitis as a predictive marker for response to biologic therapy in psoriatic arthritis

    … range of effective treatments, in particular the biologic agents for moderate to severe disease. There is however no effective biomarkers that can predict response or allow us to decide between biologic treatments based on the musculoskeletal manifestations of psoriatic disease.<br/><br/>An …

    qu-belfast Repository record for Evaluating ultrasound confirmed enthesitis as a predictive marker for response to biologic therapy in psoriatic arthritis (opens in a new tab) Download PDF for Evaluating ultrasound confirmed enthesitis as a predictive marker for response to biologic therapy in psoriatic arthritis (opens in a new tab)

  14. Η επίδραση των φλεγμονωδών νοσημάτων του εντέρου στην ποιότητα ζωής και στην παραγωγικότητα στην εργασία των ΙΦΝΕ ασθενών υπό αγωγή

    … treatment—particularly with immunomodulators and biologic agents—have significantly improved outcomes, many patients continue to face variable disease activity, persistent symptoms, or treatment-related complications. These challenges have a profound influence on everyday functioning and …

    greece Repository record for Η επίδραση των φλεγμονωδών νοσημάτων του εντέρου στην ποιότητα ζωής και στην παραγωγικότητα στην εργασία των ΙΦΝΕ ασθενών υπό αγωγή (opens in a new tab)

  15. Improving the utility of colonoscopy in colorectal neoplasia and inflammatory bowel disease

    … predictive of the need for rescue therapy with biologic agents, colectomy and readmission (UCEIS 5 (3-8) vs 4 (3-7); p=0.0035). Meta-analysis demonstrated significant reductions in PPH with prophylactic measures, and an associate cost-benefit analysis confirmed cost saving with prophylaxis (RR …

    unsw Repository record for Improving the utility of colonoscopy in colorectal neoplasia and inflammatory bowel disease (opens in a new tab)

  16. Precision Medicine in Severe Asthma

    … recent years have witnessed the introduction of biologic agents that have improved patient outcomes with regards to exacerbation reduction, asthma control, quality of life and lung function. At present, type 2 biomarkers, patient comorbidities and clinician and patient preference determine choice …

    dundee Repository record for Precision Medicine in Severe Asthma (opens in a new tab) Download PDF for Precision Medicine in Severe Asthma (opens in a new tab)

  17. Μελέτη μηχανισμών επαγωγής αυτοανοσίας σε ασθενείς με συστηματικά ρευματικά νοσήματα που λαμβάνουν θεραπεία με αντι-TNFα βιολογικούς παράγοντες

    Biologic agents against ΤΝFα have been widely used for the management of systemic inflammatory disorders, such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and Crohn’s disease. However, it soon became apparent that patients under ΤΝFα blockade commonly develop serologic …

    greece Repository record for Μελέτη μηχανισμών επαγωγής αυτοανοσίας σε ασθενείς με συστηματικά ρευματικά νοσήματα που λαμβάνουν θεραπεία με αντι-TNFα βιολογικούς παράγοντες (opens in a new tab)

  18. Biological therapy for moderate-to-severe psoriasis: a 5-year analysis of patients from lithuania /

    … 76,000 patients in Lithuania (prevalence ~2%). Biological agents targeting tumour necrosis factor (TNF-α) and interleukins 12/23, 17, and 23 represent one of the principal systemic treatment options for moderate-to-severe psoriasis. Despite extensive international clinical trial and registry …

    vilnius Repository record for Biological therapy for moderate-to-severe psoriasis: a 5-year analysis of patients from lithuania / (opens in a new tab)

  19. Μελέτη βιομορίων σε λεμφοκύτταρα ασθενών με αυτοάνοσα ρευματικά νοσήματα

    … disease modifying antirheumatic drugs and biological agents) and in two groups according to rheumatoid factor (seronegative, seropositive). The statistical analysis was conducted with SPSS 18 statistical package and non-parametric methods were used. CD3CD4 and CD4CD26 T lymphocytes were …

    greece Repository record for Μελέτη βιομορίων σε λεμφοκύτταρα ασθενών με αυτοάνοσα ρευματικά νοσήματα (opens in a new tab)

Page 1 of 2